Your search returned 68 results.

Results
	61.	Expression of tissue factor and tissue factor pathway inhibitor in situ in laryngeal carcinoma. [electronic resource] by Wojtukiewicz, M Z Zacharski, L R Ruciñska, M Zimnoch, L Jaromin, J Rózañska-Kudelska, M Kisiel, W Kudryk, B J Producer: 20000131 In: Thrombosis and haemostasis vol. 82 Availability: No items available. Save to lists Add to cart (remove)
	62.	Malignant melanoma. Interaction with coagulation and fibrinolysis pathways in situ. [electronic resource] by Wojtukiewicz, M Z Zacharski, L R Memoli, V A Kisiel, W Kudryk, B J Rousseau, S M Stump, D C Producer: 19900430 In: American journal of clinical pathology vol. 93 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	63.	Fibrin formation on vessel walls in hyperplastic and malignant prostate tissue. [electronic resource] by Wojtukiewicz, M Z Zacharski, L R Memoli, V A Kisiel, W Kudryk, B J Moritz, T E Rousseau, S M Stump, D C Producer: 19910313 In: Cancer vol. 67 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	64.	Thrombin increases the metastatic potential of tumor cells. [electronic resource] by Wojtukiewicz, M Z Tang, D G Ciarelli, J J Nelson, K K Walz, D A Diglio, C A Mammen, E F Honn, K V Producer: 19930812 In: International journal of cancer vol. 54 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	65.	Phase II randomized study of trabectedin given as two different every 3 weeks dose schedules (1.5 mg/m2 24 h or 1.3 mg/m2 3 h) to patients with relapsed, platinum-sensitive, advanced ovarian cancer. [electronic resource] by Del Campo, J M Roszak, A Bidzinski, M Ciuleanu, T E Hogberg, T Wojtukiewicz, M Z Poveda, A Boman, K Westermann, A M Lebedinsky, C Producer: 20100108 In: Annals of oncology : official journal of the European Society for Medical Oncology vol. 20 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	66.	A phase III study comparing SB3 (a proposed trastuzumab biosimilar) and trastuzumab reference product in HER2-positive early breast cancer treated with neoadjuvant-adjuvant treatment: Final safety, immunogenicity and survival results. [electronic resource] by Pivot, X Bondarenko, I Nowecki, Z Dvorkin, M Trishkina, E Ahn, J-H Im, S-A Sarosiek, T Chatterjee, S Wojtukiewicz, M Z Shparyk, Y Moiseyenko, V Bello, M Semiglazov, V Lee, Y Lim, J Producer: 20190111 In: European journal of cancer (Oxford, England : 1990) vol. 93 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	67.	Vinorelbine plus trastuzumab combination as first-line therapy for HER 2-positive metastatic breast cancer patients: an international phase II trial. [electronic resource] by Chan, A Martin, M Untch, M Gil, M G Guillem-Porta, V Wojtukiewicz, M Kellokumpu-Lehtinen, P Sommer, H L Georgoulias, V Battelli, N Pawlicki, M Aubert, D Bourlard, T Gasmi, J Villanova, G Petruzelka, L Producer: 20061114 In: British journal of cancer vol. 95 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	68.	Treatment for primary refractory Hodgkin's disease: a comparison of high-dose chemotherapy followed by ASCT with conventional therapy. [electronic resource] by Czyz, J Szydlo, R Knopinska-Posluszny, W Hellmann, A Gozdzik, J Hansz, J Smolewski, P Robak, T Osowiecki, M Walewski, J Avigdor, A Nagler, A Zemelka, T Pawlicki, M Sawicki, Z Wojtukiewicz, M Kachel, L Holowiecki, J Charlinski, G Jedrzejczak, W W Producer: 20050209 In: Bone marrow transplantation vol. 33 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)